• Kaja Kallas
  • Moussa Faki Mahamat
  • Adrian Zenz
  • Matthew Kroenig
  • Andriy Yermak
  • Vitaly Savelyev
  • Oleksandr Korniyenko
  • Dainius Kreivys
View All
IPSE'S AUTHORS LAST 24h
Check all the Authors in the last 24h
IPSEs IN THE LAST 24H
  • Alon Liel
    Alon Liel “The move [Egypt joining South Africa's ICJ genocide case against Israel] is an unbelievable diplomatic blow to Israel. Egypt is the cornerstone of our standing in the Middle East. The connections that Israel has in the Middle East and North Africa today, including with Jordan, the UAE and Morocco, is all a result of what Egypt did 40 years ago. With Egypt joining South Africa now in The Hague, it's a real diplomatic punch. Israel would have to take it very seriously. This is what I have been warning about. It's coming from several directions. Israel has to … listen to the world - not only to the Israeli public opinion asking now for revenge. We have to look overall in the wider picture, in the long-term security of Israel, not only in the next few weeks in Gaza.” 1 hour ago
  • Franz-Stefan Gady
    Franz-Stefan Gady “The Russians have understood, just as a lot of analysts have, that the major disadvantage that Ukraine is currently suffering from is manpower. By thinning out the frontline, you are increasing the odds of a breakthrough.” 4 hours ago
  • Oleksandr Syrskyi
    Oleksandr Syrskyi “This week, the situation in Kharkiv Oblast deteriorated substantially. Currently, there are continuing battles along the state's border with Russia. The situation is challenging, but the Defence Forces are doing everything possible to maintain defensive lines and positions, resulting in defeat for the adversary.” 4 hours ago
  • John Kirby
    John Kirby “It is possible that Russia will make further advances in the coming weeks, but we do not anticipate any major breakthroughs, and over time, the influx of U.S. assistance will enable Ukraine to withstand these attacks over the course of 2024.” 5 hours ago
  • Volker Türk
    Volker Türk “I can see no way that the latest evacuation orders, much less a full assault, in an area with an extremely dense presence of civilians, can be reconciled with the binding requirements of international humanitarian law and with the two sets of binding provisional measures ordered by the International Court of Justice.” 5 hours ago
  • Volodymyr Zelenskiy
    Volodymyr Zelenskiy “It is important that partners support our soldiers and Ukrainian stability with timely supplies. Really timely. The package that really helps is the weapons brought to Ukraine, not just the ones announced.” 18 hours ago
  • Oleh Syniehubov
    Oleh Syniehubov “We clearly understand what forces the enemy is using in the north of our territory. Certainly, the escalation can grow, the pressure can increase, it can strengthen its military units, its military presence. As of now the enemy keeps pressing in the north of our region. Our forces have repelled nine attacks.” 18 hours ago
View All IPSEs inserted in the Last 24h

Pfizer-BioNTech COVID-19 vaccine distribution

Page with all the IPSEs stored in the archive related to the Context Pfizer-BioNTech COVID-19 vaccine distribution.
The IPSEs are presented in chronological order based on when the IPSEs have been pronounced.

Ursula von der Leyen
Ursula von der Leyen

“Included in our plans are also the questions of how reliable the partners, how much a partner has proven that he can deliver, and this is exactly what BioNTech/Pfizer has done. We went through initial difficulties, and the experience of overcoming together difficulties, working hard together and sticking together ... was a very good experience that builds trust. On this trust, I think we can also build the future.”

author
President of the European Commission
23 Apr 2021 5 4
Read More
Ugur Sahin
Ugur Sahin

“At the moment it doesn’t look good - a hole is appearing because there’s a lack of other approved vaccines and we have to fill the gap with our own vaccine”

author
Chief executive of Germany’s BioNTech
01 Jan 2021 3 3
Read More
Sean Marett
Sean Marett

“If I use the U.K. as an example, we got approval at 1:00 am in the morning. We approved [the] release of the vaccine and shipped it within 24 hours. Certainly from the discussions that we've had, Canada is in a good position to approve the vaccine shortly. Upon approval, we then release the vaccine and then it is shipped. We've already produced the vaccine and reserved doses for Canada.”

Cbc

author
Chief business and chief commercial officer of Germany's BioNTech
06 Dec 2020 6 4
Read More
IPSEs by Context
May
MonTueWedThuFriSatSun
0102030405
06070809101112
13141516171819
20212223242526
2728293031
IPSEs by City
IPSEs by Author
IPSEs by Entity
IPSEs by Country
arrow